Early vascular aging: pathogenesis and possibilities of drug correction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper describes in detail the concept of early vascular aging and deals with differences in the pathophysiological structural and functional changes in the arteries with aging as part of the body’s natural involution and with acceleration of this process. It shows the role of the prenatally incorporated program that subsequently exacerbates the influence of exogenous risk factors. The factors and diseases that accelerate the aging process are analyzed. Much attention is paid to the existing possibilities of influencing early vascular aging; the areas that can be potentially promising for further investigation are denoted.

Full Text

Restricted Access

About the authors

I. Avdeeva

Penza State University

Email: eliseeva.iv1@gmail.com
Candidate of Medical Sciences

N. Burko

Penza State University

Email: eliseeva.iv1@gmail.com
Candidate of Medical Sciences

O. Kvasova

Penza State University

Email: eliseeva.iv1@gmail.com

T. Aryasova

Penza State University

Email: eliseeva.iv1@gmail.com

References

  1. Reaven G. Role of insulin resistance in human disease // Diabetes. - 1988; 37 (12): 1595-607. doi: 10.2337/diab.37.12.1595.
  2. Nilsson P., Lurbe E., Laurent S. The early life origins of vascular aging and cardiovascular risk: the EVA syndrome // J. Hypertens. - 2008; 26 (6): 1049-57. doi: 10.1097/HJH.0b013e3282f82c3e.
  3. Laurent S. Defining vascular aging and cardiovascular risk // J. Hypertens. - 2012; 30: S3-8. doi: 10.1097/HJH.0b013e328353e501.
  4. Chantler P., Lakatta E. Arterial-ventricular coupling with aging and disease // Front Physiol. - 2012; 3 (90): 1-12. doi: 10.3389/fphys.2012.00090.
  5. Троицкая Е.А., Вельмакин С.В., Кобалава Ж.Д. Концепция сосудистого возраста: новый инструмент оценки сердечно-сосудистого риска // Артериальная гипертензия. - 2017; 23 (2): 160-71 doi: 10.18705/1607-419x-2017-23-2-160-171.
  6. O'Rourke M. Arterial aging: pathophysiological principles // Vasc. Med. - 2007; 12 (4): 329-41. doi: 10.1177/1358863X07083392.
  7. Spartano N., Augustine J., Lefferts W. et al. Arterial stiffness as a noninvasive tissue biomarker of cardiac target organ demage // Current Biomarker Findings. - 2014; 2014 (4): 23-34. doi: 10.2147/CBF.S38738.
  8. Hashimoto J., Ito S. Some mechanical aspects of arterial aging: physiological overview based on pulse wave analysis // Ther. Adv. Cardiovasc. Dis. - 2009; 3 (5): 367-78. doi: 10.1177/1753944709338942.
  9. Кобалава Ж.Д. Котовская Ю.В., Моисеев В.С. Артериальная гипертония. Ключи к диагностике и лечению / М.: ГЭОТАР-Медиа; 2009, 864 с.
  10. Zahner G., Gruendl M., Spaulding K. et al. The association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry // J. Vasc Surg. - 2017; 66 (5): 1518-26. doi: 10.1016/j.jvs.2017.06.068.
  11. Muiesan M., Salvetti M., Rizzoni D. et al. Pulsatile hemodinamics and microcirculation: evidence for a close relationship in hypertensive patients // Hypertension. - 2013; 61 (1 ): 130-6. doi: 10.1161/HYPERTENSIONAHA.111.00006.
  12. Laurent S., Briet M., Boutouyrie P. Large and small artery cross-talk and recent morbidity-mortality trials in hypertension // Hypertension. - 2009; 54 (2): 388-92. doi: 10.1161/HYPERTENSIONAHA.109.133116.
  13. de Rezende Mikael L., de Paiva A., Gomes M. et al. Vascular aging and arterial stiffness // Arq. Bras. Cardiol. - 2017; 109 (3): 253-8. doi: 10.5935/abc.20170091.
  14. Cruickshank K., Riste L., Anderson S. et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? // Circulation. - 2002; 106 (16): 2085-90. doi: 10.1161/01.CIR.0000033824.02722.
  15. Nillson P., Olsen M., Laurent S. Early vascular aging (EVA). New directions in cardiovascular protection / Elsevier Inc., 2015; 376 p.
  16. Dratva J., Probst-Hensch N., Schmidt-Trucksäss A. et al. Atherogenesis in youth - early consequence of adolescent smoking // Atherosclerosis. - 2013; 230 (2): 304-9. doi: 10.1016/j.atherosclerosis.2013.08.004.
  17. Chung J., Lee Y., Kim J. et al. Reference Values for the Augmentation Index and Pulse Pressure in Apparently Healthy Korean Subjects // Korean. Circ. J. -2010; 40: 165-71. DOI: 10.4070 /kcj.2010.40.4.165.
  18. Borghi C., Dormi A., D’Addato S. et al. Trends in blood pressure control and antihypertensive treatment in clinical practice: the Brisighella Heart // J. Hypertens. - 2004; 22 (9): 1707-16. doi: 10.1097/00004872-200409000-0001.
  19. Кушнаренко Н.Н., Говорин А.В. Клиническое значение эндотелиальной дисфункции и синдрома инсулинорезистентности у больных подагрой с артериальной гипертензией // Рациональная фармакотерапия в кардиологии. - 2013; 9 (5): 482-7 doi: 10.20996/1819-6446-2013-9-5.
  20. Sadat U., Howarth S., Usman A. et al. Effect of low- and high-dose atorvastatin on carotid artery distensibility using carotid magnetic resonance imaing - a post-hoc sub group analysis of ATHEROMA (Atorvastatin Therapy: Effects On Reduction Of Macrophage Activity) Study // J. Atheroscler. Thromb. - 2013; 20 (1): 46-56. doi: 10.5551/jat.12633.
  21. Кобалава Ж.Д., Виллевальде С.В., Мерай И.А. и др. Влияние сакубитрил / валсартана на натрийурез, диурез и уровень артериального давления у пациентов с артериальной гипертонией // Рациональная фармакотерапия в кардиологии. - 2017; 13 (3): 370-7 https://doi.org/10.20996/1819-6446-2017-13-3-370-377.
  22. Карпов Ю.А. Как предупредить раннее сосудистое старение у пациентов с артериальной гипертонией? // Атмосфера. Новости кардиологии. - 2016; 3: 2-10
  23. Azevedo A., Prado A., Antonio R. et al. Matrix metalloproteinases are involved in cardiovascular diseases // Basic Clin. Pharmacol. Toxicol. - 2014; 115: 301-14. doi: 10.1111/bcpt.12282.
  24. Oliver J., Dear J., Webb D. Clinical potential of combined organic nitrate and phosphodiesterase type 5 inhibitor in treatment-resistant hypertension // Hypertension. - 2010; 56 (1): 62-7. doi: 10.1161/HYPERTENSIONAHA.109.147686.
  25. Strôzecki P., Kurowski R., Flisinski M. et al. Advanced glycation end products and arterial stiffness in patients with diabetic nephropathy and patients with chronic kidney disease without diabetes // Pol. Arch. Med. Wewn. - 2013; 123 (11): 609-16.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies